Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adaptimmune Therapeutics (ADAP)
NASDAQ:ADAP
RESEARCH TOOLSreports
Holding ADAP?
Track your performance easily
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 102,478,668 | Insider | 40.05% | 69,070,622 | |
| 37,681,515 | Institution | 14.73% | 25,397,341 | |
| 19,500,000 | Insider | 7.62% | 13,143,000 | |
| 2,343,695 | Institution | 0.92% | 1,579,650 | |
| 1,800,000 | Insider | 0.70% | 1,213,200 | |
| 393,206 | Institution | 0.15% | 265,021 | |
| 170,537 | Institution | 0.07% | 114,942 | |
| 139,801 | Institution | 0.05% | 94,226 | |
| 130,764 | Insider | 0.05% | 88,135 | |
| 99,822 | Institution | 0.04% | 67,280 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 139,801 | Institution | 0.05% | 94,226 | |
| 99,822 | Institution | 0.04% | 67,280 | |
| 16,257 | Institution | <0.01% | 10,957 | |
| 7,944 | Institution | <0.01% | 5,354 | |
| 554 | Institution | <0.01% | 373 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 246,307 | Institution | 0.10% | 146,553 | |
| 170,537 | Institution | 0.07% | 100,821 | |
| 146,899 | Institution | 0.06% | 87,405 | |
| 34,809 | Institution | 0.01% | 20,419 | |
| 6 | Institution | <0.01% | 4 |
FAQ
Who Owns Adaptimmune Therapeutics (ADAP)?
Currently, no data Available
What percentage of Adaptimmune Therapeutics (ADAP) stock is held by institutional investors?
Currently, no data Available
What percentage of Adaptimmune Therapeutics (ADAP) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Adaptimmune Therapeutics (ADAP)?
David Mott owns the most shares of Adaptimmune Therapeutics (ADAP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.